Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2018. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 466157013 | Troglitazone 200mg tablet | en | Synonym | Inactive | Entire term case sensitive | SNOMED CT core module |
| 718760012 | Troglitazone 200mg tablet (substance) | en | Fully specified name | Inactive | Only initial character case insensitive | SNOMED CT core module |
| 1190929013 | Troglitazone 200mg tablet (product) | en | Fully specified name | Inactive | Entire term case sensitive | SNOMED CT core module |
| 3472336015 | Product containing troglitazone 200 mg/1 each oral tablet | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3489425019 | Product containing troglitazone 200 mg/1 each oral tablet (clinical drug) | en | Fully specified name | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3500856015 | Troglitazone 200 mg oral tablet | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| 3566925011 | Product containing only troglitazone 200 mg/1 each oral tablet | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3566926012 | Product containing only troglitazone 200 mg/1 each oral tablet (clinical drug) | en | Fully specified name | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3683861016 | Product containing precisely troglitazone 200 milligram/1 each conventional release oral tablet | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3683862011 | Product containing precisely troglitazone 200 milligram/1 each conventional release oral tablet (clinical drug) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely troglitazone 200 milligram/1 each conventional release oral tablet | Is a | Product containing troglitazone | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely troglitazone 200 milligram/1 each conventional release oral tablet | Has active ingredient | Oral hypoglycemic | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely troglitazone 200 milligram/1 each conventional release oral tablet | Has active ingredient | Troglitazone | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely troglitazone 200 milligram/1 each conventional release oral tablet | Has manufactured dose form | Tablet | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely troglitazone 200 milligram/1 each conventional release oral tablet | Has manufactured dose form | Conventional release oral tablet | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely troglitazone 200 milligram/1 each conventional release oral tablet | Is a | Product manufactured as oral dose form | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely troglitazone 200 milligram/1 each conventional release oral tablet | Has active ingredient | Troglitazone | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely troglitazone 200 milligram/1 each conventional release oral tablet | Has basis of strength substance | Troglitazone | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely troglitazone 200 milligram/1 each conventional release oral tablet | Has presentation strength numerator value | 200 | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely troglitazone 200 milligram/1 each conventional release oral tablet | Has presentation strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely troglitazone 200 milligram/1 each conventional release oral tablet | Has presentation strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely troglitazone 200 milligram/1 each conventional release oral tablet | Has presentation strength denominator unit | Tablet | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely troglitazone 200 milligram/1 each conventional release oral tablet | Has precise active ingredient | Troglitazone | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely troglitazone 200 milligram/1 each conventional release oral tablet | Has unit of presentation | Tablet | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely troglitazone 200 milligram/1 each conventional release oral tablet | Is a | Product containing troglitazone in oral dose form (medicinal product form) | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely troglitazone 200 milligram/1 each conventional release oral tablet | Count of base of active ingredient | 1 | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely troglitazone 200 milligram/1 each conventional release oral tablet | Is a | Product containing only troglitazone in oral dose form (medicinal product form) | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Troglitazone 200mg tablet - product | Is a | False | Product containing precisely troglitazone 200 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR